Interesting Image

Imaging Features of Breast Plasmacytoma

10.4274/mirt.galenos.2021.42650

• Şeyma Babaoğlu
• Necdet Poyraz
• Buğra Kaya
• Sıddıka Fındık
• Sinan Demircioğlu

Received Date: 06.02.2021 Accepted Date: 17.03.2021 Mol Imaging Radionucl Ther 2022;31(2):163-165 PMID: 35771076

• Abstract
• Full Text
• Video - Image
• References
• 7
• 679

Extramedullary plasmacytoma (EMP) occurs as a result of abnormal proliferation of plasma cells outside the bone marrow. Breast plasmacytomas are rare. Radiologically, they can be confused with benign and malignant lesions of the breast. It is important to be able to diagnose EMP in the breast since the treatment strategy is different from that of other lesions and allows for the diagnosis and early treatment of multiple myeloma (MM) relapse. We report imaging and clinicopathological findings of an EMP case in which a 65-year-old patient with MM in remission presented with breast masses.

Keywords: PET/CT, plasmacytoma, breast, ultrasonography, mammography

Ethics

Informed Consent: It has received institutional ethics approval.

Peer-review: Externally and internally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: S.D., S.F., Concept: B.K., Design: N.P., Data Collection or Processing: Ş.B., Analysis or Interpretation: N.P., B.K., S.F., S.D., Literature Search: Ş.B., Writing: Ş.B.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

Images

1. Eden JK, Borgen R, Haq R, Dobrashian R. A rare imaging case of bilateral plasmacytoma of the breast. BJR Case Rep 2020;6:20190131.
2. Park YM. Imaging findings of plasmacytoma of both breasts as a preceding manifestation of multiple myeloma. Case Rep Med 2016;2016:6595610.
3. Surov A, Holzhausen HJ, Ruschke K, Arnold D, Spielmann RP. Breast plasmacytoma. Acta Radiol 2010;51:498-504.
4. Lu YY, Chen JH, Lin WY, Liang JA, Wang HY, Tsai SC, Kao CH. FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: a systematic review and meta-analysis. Clin Nucl Med 2012;37:833-837.
5. Durie BG, Waxman AD, D’Agnolo A, Williams CM. Whole-body (18)F-FDG PET identifies high-risk myeloma. J Nucl Med 2002;43:1457-1463.
6. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15:e538-e548.
7. Binesh F, Vahedian HA, Shabani M, Zare S, Shahcheraghi SH. Extramedullary plasmacytoma of the breast: A case report and literature review. Acta Med Iran 2018;56:204-207.
8. Lee HS, Kim JY, Kang CS, Kim SH, Kang JH. Imaging features of bilateral breast plasmacytoma as unusual initial presentation of multiple myeloma: case report and literature review. Acta Radiol Short Rep 2014;3:2047981614557666.